Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NASDAQ | Common Stock
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders.
It manufactures and sells implants and instruments through third-party suppliers.
The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization.
It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.
The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally.
Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 24 | -0.34 Increased by +15.00% | -0.31 Decreased by -9.68% |
| Feb 27, 24 | -0.37 Decreased by -12.12% | -0.25 Decreased by -48.00% |
| Nov 6, 23 | -0.35 Increased by 0.00% | -0.28 Decreased by -25.00% |
| Aug 3, 23 | -0.43 Decreased by -19.44% | -0.28 Decreased by -53.57% |
| May 4, 23 | -0.40 Increased by +6.98% | -0.31 Decreased by -29.03% |
| Feb 28, 23 | -0.33 Increased by +17.50% | -0.28 Decreased by -17.86% |
| Nov 3, 22 | -0.35 Increased by +2.78% | -0.30 Decreased by -16.67% |
| Aug 4, 22 | -0.36 Increased by +7.69% | -0.29 Decreased by -24.14% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 118.26 M Increased by +31.64% | -42.65 M Decreased by -15.28% | Decreased by -36.07% Increased by +12.42% |
| Jun 30, 23 | 116.92 M Increased by +38.94% | -51.38 M Decreased by -37.67% | Decreased by -43.94% Increased by +0.92% |
| Mar 31, 23 | 109.11 M Increased by +53.82% | -43.53 M Decreased by -1.60% | Decreased by -39.89% Increased by +33.95% |
| Dec 31, 22 | 105.94 M Increased by +43.24% | -34.99 M Increased by +12.94% | Decreased by -33.02% Increased by +39.22% |
| Sep 30, 22 | 89.84 M Increased by +42.87% | -37.00 M Increased by +14.02% | Decreased by -41.18% Increased by +39.82% |
| Jun 30, 22 | 84.15 M Increased by +35.18% | -37.32 M Increased by +2.32% | Decreased by -44.35% Increased by +27.74% |
| Mar 31, 22 | 70.93 M Increased by +60.77% | -42.84 M Decreased by -87.07% | Decreased by -60.40% Decreased by -16.36% |
| Dec 31, 21 | 73.96 M Increased by +68.27% | -40.19 M Decreased by -49.96% | Decreased by -54.33% Increased by +10.88% |